
The average Hikma Pharmaceuticals Investor Relations in Rochester, MN earns an estimated $64,610 annually. Hikma Pharmaceuticals' Investor Relations compensation is $17,321 less than the US average for a Investor Relations.
Last updated a month ago.
The majority of Investor Relations at Hikma Pharmaceuticals believe they're compensated fairly. 100% of Investor Relations at Hikma Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Hikma Pharmaceuticals